Novel broad-spectrum activity-based probes to profile malarial cysteine proteases

Michele S Y Tan1, Dara Davison1, Mateo I Sanchez2

  • 1The Francis Crick Institute, London, United Kingdom.

Plos One
|January 11, 2020
PubMed
Summary

New probes effectively label malaria parasite and human cysteine proteases, aiding drug target validation. These broad-spectrum activity-based probes improve specificity for developing antimalarial drugs.